290 related articles for article (PubMed ID: 10809402)
1. Altered redox state of platelet coenzyme Q10 in Parkinson's disease.
Götz ME; Gerstner A; Harth R; Dirr A; Janetzky B; Kuhn W; Riederer P; Gerlach M
J Neural Transm (Vienna); 2000; 107(1):41-8. PubMed ID: 10809402
[TBL] [Abstract][Full Text] [Related]
2. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
Shults CW; Haas RH; Beal MF
Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
[TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase B activity in "de novo" and l-dopa treated parkinsonian patients and controls.
Kuhn W; Müller T; Gerstner A; Winkel R; Goetz ME
Can J Neurol Sci; 1998 Aug; 25(3):249-51. PubMed ID: 9706728
[TBL] [Abstract][Full Text] [Related]
4. Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans.
Vasta V; Sedensky M; Morgan P; Hahn SH
Mitochondrion; 2011 Jan; 11(1):136-8. PubMed ID: 20849980
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels and redox status of coenzyme Q10 in infants and children.
Menke T; Niklowitz P; Schlüter B; Weber M; Buschatz D; Trowitzsch E; Andler W
Biofactors; 2004; 20(3):173-81. PubMed ID: 15665387
[TBL] [Abstract][Full Text] [Related]
6. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
[TBL] [Abstract][Full Text] [Related]
7. A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
Andreu N; Damase-Michel C; Senard JM; Rascol O; Montastruc JL
Mov Disord; 1997 May; 12(3):293-6. PubMed ID: 9159721
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K
JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227
[TBL] [Abstract][Full Text] [Related]
10. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice.
Sohal RS; Kamzalov S; Sumien N; Ferguson M; Rebrin I; Heinrich KR; Forster MJ
Free Radic Biol Med; 2006 Feb; 40(3):480-7. PubMed ID: 16443163
[TBL] [Abstract][Full Text] [Related]
11. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
12. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
LeWitt P; Oakes D; Cui L
Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
Lyytinen J; Kaakkola S; Ahtila S; Tuomainen P; Teräväinen H
Mov Disord; 1997 Jul; 12(4):497-505. PubMed ID: 9251066
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.
Shults CW; Haas RH; Passov D; Beal MF
Ann Neurol; 1997 Aug; 42(2):261-4. PubMed ID: 9266740
[TBL] [Abstract][Full Text] [Related]
16. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
Storch A
Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.
Cleren C; Yang L; Lorenzo B; Calingasan NY; Schomer A; Sireci A; Wille EJ; Beal MF
J Neurochem; 2008 Mar; 104(6):1613-21. PubMed ID: 17973981
[TBL] [Abstract][Full Text] [Related]
18. Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells.
Duberley KE; Heales SJ; Abramov AY; Chalasani A; Land JM; Rahman S; Hargreaves IP
Int J Biochem Cell Biol; 2014 May; 50():60-3. PubMed ID: 24534273
[TBL] [Abstract][Full Text] [Related]
19. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?
Seet RC; Lim EC; Tan JJ; Quek AM; Chow AW; Chong WL; Ng MP; Ong CN; Halliwell B
Antioxid Redox Signal; 2014 Jul; 21(2):211-7. PubMed ID: 24410614
[TBL] [Abstract][Full Text] [Related]
20. Validation and application of an HPLC-EC method for analysis of coenzyme Q10 in blood platelets.
Miles MV; Tang PH; Miles L; Steele PE; Moye MJ; Horn PS
Biomed Chromatogr; 2008 Dec; 22(12):1403-8. PubMed ID: 18655217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]